All email addresses at the HRA are changing in the coming weeks and this change will be complete by March 2020.
HRA staff email addresses will be standardised as email@example.com. A full list of contact email addresses for the Research Ethics Committees is now available here.
If you use the HRA staff member’s @nhs.net email address to contact them after they have moved to their new email address, you will receive a response containing their new details but your email won’t be automatically forwarded.
If you are unsure which contact information to use for the individual or service you require, please contact the HRA mainline on 020 797 22545 or use their contact form.
Make sure to check your junk mail if you are expecting emails from the HRA or an NHS REC as they often are sent there instead. Please add them to your safe senders list if this is the case to make sure you don’t miss any important study emails!
SoECAT stands for the ‘Schedule of Events Cost Attribution Tool’ – either a SoECAT or a Schedule of Events (SoE) is required whenever you are conducting clinical research in the NHS or Social Care. Further information and clarification is provided below.
What is the purpose of the SoECAT?
- The SoECAT is a way of providing clarity to participating NHS organisations on the cost attributions associated with a study.
- The template is designed to support correct cost attribution at application for Research Cost funding, to ensure that full site level Research Costs are recovered.
When is a SoECAT required?
- A SoECAT is required by National Institute for Health Research (NIHR) and NIHR non-commercial partner research funders where the call relates to studies that may involve participants under an NHS or Health and Social Care duty of care.
- In some cases, your study may be funded by an NIHR infrastructure award which does not cover Excess Treatment Costs (ETCs) – in these cases, a SoECAT would be required in order to access the ETC process for England. Further information on ETCs can be found here.
- In cases where your study is not funded by the NIHR or a NIHR non-commercial partner, but you wish to make an application to the NIHR CRN Portfolio, you will need to complete a SoECAT.
How do I complete one?
- The NIHR have recently released new guidance on how to complete a SoECAT which can be found here.
When is it completed and where does the SoECAT go when it is completed?
- The SoECAT should be completed at the funding application stage.
- The form must be authorised by an AcoRD Specialist prior to submission for Research Cost funding.
- It should be submitted alongside your other supporting documents when applying through the IRAS system for NHS Ethics approval and/or Health Research Authority approval*.
- The SoECAT/SoE is then sent to your participating NHS/HSC organisations as part of the Local Information Pack at the site study set-up stage.
*Where there is no external funding attached to a project, the Schedule of Events should be used instead of a SoECAT.
Where can I get further support and guidance?
- Your research funder should have guidance you can follow if you are unsure about whether your application requires a SoECAT at the Research Cost funding application stage.
- Get in touch with Suzy Wignall, the Clinical Governance Advisor, or your Funding Development Officer.
- Further information about the SoECAT can be found here.
Remember – support and guidance is on offer at BU if you are thinking of conducting clinical research, whether in the NHS, private healthcare or social care – get in touch with Research Ethics. You can also take a look at the Clinical Governance blog for resources and updates.
Following the implementation of GDPR in May of this year, the Health Research Authority released transparency wording for use in Participant Information Sheets.
The recommended wording for data transparency has been updated following consultation with various stakeholders and public involvement and feedback on the initial published wording to provide a clearer more layered approach.
The user group developed a short summary text for the Participant Information Sheet which is supplemented by a generic leaflet. The text for both is now live on the HRA website.
What information should be used in my PI Sheet?
The HRA website section is here. Click on ‘Transparency wording for all sponsors’ – this will take you to this page which contains the information to be used.
To access the text to be used in preparing the leaflet to accompany your PI Sheet, click here. If you are on the HRA website section, the text appears once you click the heading ‘Template wording for generic information document’.
What does the revision in text mean for me?
- If you have already updated your information sheets with the previous wording, you do not need to do anything.
- The revised wording can be uses for new studies, but the HRA will accept the previous wording if you have already submitted your application or prepared your information sheet for submission.
- If you do wish to change your wording to the new text, please email Research Ethics so that your participating sites can be contacted.
If you have any queries or concerns please email Research Ethics.
You will hopefully have seen numerous blog posts regarding the Health Research Authority’s (HRA) commitment to research transparency. This was prompted in response to the House of Commons Science and Technology Committee report last year on clinical trials transparency, which showed that nearly half of clinical trials fail to publish their results. In their report, the committee made a number of recommendations to the Health Research Authority in order to rectify the situation.
The HRA have recently launched a consultation on their new draft strategy for research transparency – #MakeItPublic. You can find out more about the campaign here on their website where there are also pages outlining their plans and visions for this area of improvement.
If you would like to have your say and be a part of the consultation, BU has an internal survey you can complete. The survey will close on Friday 16th August and replies will be combined to create an institutional response.